Patent details

EP2981624 Title: METHODS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY AND PREDICTING RESPONSE TO CANCER TREATMENT

Basic Information

Publication number:
EP2981624
PCT Application Number:
US2014033014
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP147794036
PCT Publication Number:
WO2014165785
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY AND PREDICTING RESPONSE TO CANCER TREATMENT
French Title of Invention:
MÉTHODES DESTINÉES À ÉVALUER LE DÉFICIT DE RECOMBINAISON HOMOLOGUE ET PREDIRE LA REPONSE A UN TRAITEMENT CONTRE LE CANCER
German Title of Invention:
VERFAHREN ZUR BEURTEILUNG EINES MANGELS AN HOMOLOGER REKOMBINATION UND ZUR VORHERSAGE DER REAKTION AUF EINE KREBSTHERAPIE
SPC Number:

Dates

Filing date:
04/04/2014
Grant date:
18/12/2019
EP Publication Date:
10/02/2016
PCT Publication Date:
09/10/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/12/2019
EP B1 Publication Date:
18/12/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
04/04/2020
Expiration date:
04/04/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/12/2019
 
 

Name:
Myriad Genetics, Inc.
Address:
320 Wakara Way, Salt Lake City, UT 84108, United States (US)

Inventor

1

Name:
ABKEVICH, Victor
Address:
United States (US)

2

Name:
TIMMS, Kirsten
Address:
United States (US)

3

Name:
GUTIN, Alexander
Address:
United States (US)

Priority

1

Priority Number:
201361809105 P
Priority Date:
05/04/2013
Priority Country:
United States (US)

2

Priority Number:
201361913762 P
Priority Date:
09/12/2013
Priority Country:
United States (US)

Classification

IPC classification:
C12Q 1/6886;

Publication

European Patent Bulletin

1

Issue number:
201951
Publication date:
18/12/2019
Description:
Grant (B1)

2

Issue number:
202007
Publication date:
12/02/2020
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202312
Publication date:
22/03/2023
Description:
Opposition rejected; Patent maintained as granted

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages